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Abstract
Background:  Awareness of the significance of peripheral arterial disease is increasing, but
quantitative estimates of the ensuing burden and the impact of other risk factors remains limited.
The objective of this study was to fill this need.
Methods:  Morbidity and mortality were examined in 16,440 index patients diagnosed with
peripheral arterial disease in Saskatchewan, Canada between 1985 and 1995. Medical history and
patient characteristics were available retrospectively to January 1980 and follow-up was complete
to March 1998. Crude and adjusted event rates were calculated and Kaplan-Meier survival curves
estimated. Cox proportional hazards analyses were conducted to examine the effect of risk factors
on these rates. Patients suffering a myocardial infarction or ischemic stroke in Saskatchewan
provided two reference populations.
Results: Half of the index patients were male; the majority was over age 65; 73% had at least one
additional risk factor at index diagnosis; 10% suffered a subsequent stroke, another 10% a
myocardial infarction, and 49% died within the mean follow-up of 5.9 years. Annual mortality (8.2%)
was higher among patients with PAD than after a myocardial infarction (6.3%) but slightly lower
than that in patients suffering a stroke (11.3%). Index patients with comorbid disease (e.g., diabetes)
were at highest risk of death and other events.
Conclusion: A diagnosis of peripheral arterial disease is critical evidence of more widespread
atherothrombotic disease, with substantial risks of subsequent cardiovascular events and death.
Given that the majority has additional comorbidities, these risks are further increased.
Background
Atherothrombosis is a chronic affliction of the arterial vas-
cular tree. While its coronary and intracerebral manifesta-
tions are well recognized, its effects on the peripheral
vasculature and the ensuing complications are less so.
This condition, peripheral arterial disease, is best known
for the ischemic pain it produces, but significant impair-
ment can exist before it is symptomatic. Estimates of the
prevalence of peripheral arterial disease vary widely, from
4.3% to 57%, depending on how the disease is identified,
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the age and risk factor distributions [1-6]. Advancing age,
male gender, a history of diabetes and smoking are asso-
ciated with a higher risk of peripheral arterial disease
[7,8]. Approximately one-quarter to more than one-half
of patients diagnosed with peripheral arterial disease
experience the frequently painful symptoms associated
with this diagnosis. Rates of newly diagnosed disease are
in the range of 7% to 13% per year [1,7-10].
Awareness and understanding of the significance of a
peripheral arterial disease diagnosis is increasing, but pre-
cise quantitative estimates of the burden and our under-
standing of the prognosis and impact of other risk factors
remains limited [11]. Documentation of the burden of
this disease can provide the means to better understand its
course and, in turn, to make more effective decisions in
the management of patients. In this paper, we report the
results of analyses of the morbidity and mortality experi-
enced by a large cohort of patients diagnosed with periph-
eral arterial disease.
Methods
Study population
The health care databases maintained by Saskatchewan
Health were the source of data for this study. Saskatch-
ewan Health is a provincial government department that
administers a universal public health insurance program
for approximately one million residents. Its administra-
tive databases (e.g., formulary outpatient prescriptions,
physician services, hospitalizations, and vital statistics)
can be linked electronically using unique patient identifi-
ers [12].
Residents of Saskatchewan, Canada, covered by Saskatch-
ewan Health and eligible for outpatient prescription drug
benefits (the prescription drug plan does not capture the
claims of Registered Canadians of First Nations), diag-
nosed with peripheral arterial disease between January 1,
1985 and December31, 1995, during a hospitalization or
physician consultation were eligible if at least 21 years of
age at the time of diagnosis; no other exclusion criteria
were specified. Patients with peripheral arterial disease
were identified using the International Classification of
Diseases (ICD-9) codes 440, 440.2, or 443.9. The broader
three-digit code 443 was allowed if it coincided with doc-
umentation of a prescription for pentoxifylline on the
assumption that all patients who received this prescrip-
tion were diagnosed with peripheral arterial disease [13].
Patient history was available from January 1, 1980 and
follow-up through March 1998 or until a patient could no
longer be followed due to emigration or death. The date
of first diagnosis, either hospital admission or physician
visit depending on where the index diagnosis was
recorded, was taken as the date of entry into the study.
Reference populations
Analyses were also carried out in reference populations
comprised separately of Saskatchewan resident's age 21
years and older, without preexisting peripheral arterial
disease, who suffered a myocardial infarction (ICD-9 code
410) or stroke (ICD-9 codes 433, 434, 436, and 362.3)
between January 1, 1990 and December31, 1995. The
same selection criteria used to identify the subjects with
peripheral arterial disease were applied to these popula-
tions. The first diagnosis or event on record within the
study dates was used to define the populations. For exam-
ple, a subject with a diagnosis of peripheral arterial dis-
ease in October 1988 and a subsequent myocardial
infarction recorded in January 1990 was assigned to the
peripheral arterial disease cohort.
Outcomes and risk factors
Hospitalization records subsequent to the index diagnosis
were used to identify outcome events, namely angina,
transient ischemic attack, myocardial infarction, or stroke.
To estimate the event rates, each event was considered
independent of the others. The hospital admission date
was taken as the time the outcome took place. Deaths
were determined from the vital statistics file.
For subjects whose index event was a myocardial infarc-
tion, subsequent hospitalizations for myocardial infarc-
tion were only considered if they occurred at least seven
days after the index event. Similarly, recurrence of stroke
had to be at least seven days after an index stroke. For the
outcome cluster consisting of angina, transient ischemic
attack, myocardial infarction, stroke or cardiovascular
death, the first occurrence of any of these events was
taken.
Event-free time and survival were measured from the date
of the index event (index date) to the time of hospitaliza-
tion for the outcome or the date of death, as appropriate.
If no outcome event occurred, then the subject's time was
considered right-censored and the study end date (or date
of emigration) was taken as the end of the period.
The patients' medical history prior to index event (availa-
ble back to January 1980) was examined to identify other
diseases documented prior to the qualifying diagnosis.
Risk factors of interest included: male gender, age greater
than 65 years at index diagnosis, prior myocardial infarc-
tion, prior stroke, diabetes, hypercholesterolemia, conges-
tive heart failure, angina, atrialfibrillation, hypertension,
and transient ischemic attack. The presence of each risk
factor was determined based on ICD-9 coding of diag-
noses recorded at hospitalizations or doctor visits prior to
the index diagnosis. Given the relatively long inclusion
period, we also considered the possibility of a calendarBMC Cardiovascular Disorders 2005, 5:14 http://www.biomedcentral.com/1471-2261/5/14
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trend by including an indicator of the time of diagnosis of
peripheral arterial disease, prior to January 1, 1990 or
afterwards.
Analyses
Descriptive analyses were carried out to characterize the
study and reference populations in terms of age, gender,
setting of diagnosis (hospital versus outpatient), and
medical history. The occurrence of each outcome event
was independently estimated as a hazard (events/patient
years). The Kaplan-Meier approach was used to determine
the cumulative proportion (%) of patients suffering any
one of the outcome events over time. To assess the impact
of individual risk factors on the rate of outcome events,
Cox proportional hazards analyses were conducted. Next,
the number of risk factors present at diagnosis was tallied
and the average hazard rates of myocardial infarction,
stroke, and death in each group were compared to those
of the patients with no risk factors at diagnosis. Compari-
sons were also made by gender.
Mortality among patients with peripheral arterial disease
was evaluated using the Kaplan-Meier method and
through estimation of average hazard rates. These were
compared to post-acute mortality in each reference popu-
lation (myocardial infarction and stroke) – deaths
recorded in the first 30 days following those acute index
events were excluded to accord better with the chronic
nature of the diagnoses. The patients' medical history
prior to index event (available back to January 1980) was
examined to identify other diseases documented prior to
the qualifying diagnosis.
Results
Population characteristics
The study population consisted of 16,440 patients diag-
nosed with peripheral arterial disease between 1985 and
1995 with an average follow-up of 5.9 (± 3.6) years. Most
patients (90%) were identified on a physician visit and a
majority presented with at least one comorbid condition
at the time of diagnosis, as displayed in Table 1. Reference
populations were comprised of 15,590 patients who suf-
fered a myocardial infarction, 2,700 of whom died during
the first 30 days, and 18,704 who suffered a stroke, of
whom 1,877 died during the first 30 days. One-third of
patients with an index stroke and one-half of patients with
an index myocardial infarction were identified in hospital
(Table 1).
Outcome events
Subsequent myocardial infarction, stroke, and angina
each occurred in approximately 10% of the peripheral
arterial disease population at rates varying between 16.8
and 17.1 per 1,000 patient years (Table 2). Transient
ischemic attack occurred in only 3.7% of these patients at
a rate of 6.3 per 1,000 patient years.
Only half of all patients remained alive at the end of fol-
low-up. The crude five-year death rate among patients
diagnosed with peripheral arterial disease was 33.2% – a
rate of 82.4 deaths per 1,000 patient years (Figure 1).
When all outcome events and cardiovascular deaths are
evaluated together, it is estimated that 16.0% of patients
had an event by the end of the first year after diagnosis
and this rose to about one-third by three years. In compar-
ison, 13.5% of patients in the myocardial infarction
Table 1: Patient populations. Patient characteristics and medical history for each population at the time of the index diagnosis. Age is 
reported as mean ± standard deviation. All other values are reported as number (%).
Reference Populations
Item PAD
N = 16,440
MI
 N = 15,590
Stroke
 N = 18,704
Age (years) 67.3 ± 9.2 66.9 ± 11.1 70.5 ± 9.9
Male 9,030 (55) 9,955 (64) 9,723 (52)
Qualifying diagnosis in hospital 1,659 (10) 8,954 (56) 6,733 (36)
Medical History
Atrial Fibrillation 862 (5) 905 (6) 1,812 (10)
Angina 5,446 (33) 6,435 (41) 4,849 (26)
Congestive Heart Failure 4,178 (25) 3,902 (25) 5,324 (29)
Diabetes Mellitus 3,172 (19) 3,693 (24) 4,487 (24)
Hypercholesterolemia 1,128 (7) 1,498 (10) 1,183 (6)
Hypertension 9,554 (58) 9,502 (61) 12,603 (67)
Ischemic Stroke 2,111 (13) 1,001 (6) 4,408 (24)
Myocardial Infarction 2,868 (18) 3,672 (24) 2,211 (12)
Transient Ischemic Attack 2,217 (14) 1,372 (9) 5,151 (28)BMC Cardiovascular Disorders 2005, 5:14 http://www.biomedcentral.com/1471-2261/5/14
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Table 2: Event risk. First cardiovascular events of each type and all-cause deaths subsequent to a diagnosis of peripheral arterial 
disease. Event rates are reported per 1,000 person-years.
All Patients Males Females
Outcome Events (%) PY Event
Rate
Events (%) PY Event
Rate
Events (%) PY Event
Rate
Angina 1,555 (9.5) 90,734 17.1 1,012 (11.2) 48,363 20.9 543 (7.3) 42,371 12.8
TIA 601 (3.7) 94,768 6.3 306 (3.4) 51,526 5.9 295 (4.0) 43,242 6.8
MI 1,563 (9.5) 93,160 16.8 1,012 (11.2) 49,956 20.3 551 (7.4) 43,204 12.8
Stroke 1,589 (9.7) 93,066 17.1 917 (10.2) 50,309 18.2 672 (9.1) 42,757 15.7
Death 7,973 (48.5) 96,771 82.4 4,519 (50.0) 52,503 86.1 3,454 (46.6) 44,269 78.0
Patient survival Figure 1
Patient survival. Survival among patients with peripheral arterial disease compared to patients suffering a stroke or myocar-
dial infarction.
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reference population were re-hospitalized for a recurrent
myocardial infarction, at a rate of 41.2 per 1,000 person-
years, and 12.0% with angina (36.3 per 1,000 person
years). Less than 5% suffered a stroke (13.0 per 1,000 per-
son years) or a transient ischemic attack (4.6 per 1,000
person years). Among patients in the stroke reference
group, less than 5% suffered a myocardial infarction (12.4
per 1,000 person years), transient ischemic attack (11.1
per 1,000 person years) or angina (7.3 per 1,000 person
years), whereas, 16.6% had a recurrent stroke (54.7 per
1,000 person years). Approximately two-thirds (59.6%)
of patients with a myocardial infarction and one-half
(51.3%) of those with a stroke were alive at the end of
follow-up.
Mortality
The crude five-year death rate among patients diagnosed
with peripheral arterial disease was 33.2%. When adjusted
for duration of follow-up, the rate is 82.4 deaths per 1,000
patient years. Compared to the reference populations,
mortality is lower than among patients who suffer an
index stroke (41.8% crude rate; 113.1 per 1,000 patient
years adjusted) but higher than that among patients who
suffer an index myocardial infarction (26.6%; 63.2 per
1,000 patient years). Survival in each group, excluding
deaths during the acute period (first 30 days) for index
myocardial infarction and index stroke, is displayed in
Figure 1.
Impact of risk factors
On average, women were older than the men (68.2 ± 8.9
vs 66.5 ± 9.4). Over the course of an average follow-up of
six years, men were considerably more likely to manifest
further atherothrombotic complications (Table 2): angina
(63% more in men), myocardial infarction (59% more),
stroke (16% more), and death (10% more). Transient
ischemic attack, however, occurred less often in men
(13% less).
As might be expected, prior myocardial infarction (hazard
ratio = 1.53, 95% CI 1.35–1.73) was a strong risk factor
for a subsequent myocardial infarction. A prior stroke was
also a predictor of myocardial infarction (hazard ratio =
1.26, 1.08–1.46) and, more strongly, of subsequent stroke
(hazardratio = 2.23, 1.96–2.53). In addition, a transient
ischemic attack (hazard ratio = 1.35, 1.18–1.54) was a
powerful predictor of stroke. Even amongst patients with
no history of atherothrombotic disease (myocardial inf-
arction or stroke), however, 7.5% suffered a myocardial
infarction and 8.0% a stroke – rates of 13.5 and 14.0
events per 1,000 patient years, respectively.
Cox proportional hazards analyses conducted to deter-
mine the effect of various potential risk factors show that
the majority of the eleven considered are significant pre-
dictors of future stroke, myocardial infarction and death.
Apart from prior myocardial infarction or stroke, the risk
of myocardial infarction was significantly increased with
male gender (hazard ratio = 1.53, 1.38–1.71), age over 65
years (hazard ratio = 1.50, 1.34–1.69), angina (hazard
ratio = 1.47, 1.31–1.64), diabetes mellitus (hazard ratio =
1.50, 1.33–1.68), heart failure (hazard ratio = 1.15, 1.02–
1.30), and hypertension (hazard ratio = 1.31, 1.18–1.46).
Many of these same conditions also significantly
increased the risk of stroke: male gender (hazard ratio =
1.26, 1.13–1.39), age over 65 years (hazard ratio = 1.98,
1.73–2.26), atrial fibrillation (hazard ratio = 1.64, 1.36–
1.98), diabetes mellitus (hazard ratio = 1.50, 1.34–1.69),
heart failure (hazard ratio = 1.20, 1.07–1.35), and hyper-
tension (hazard ratio = 1.51, 1.35–1.69). Increased risk of
death was associated with male gender (hazard ratio =
1.27, 1.21–1.32), age over 65 years (hazardratio = 3.65,
3.39–3.92), atrial fibrillation (hazard ratio = 1.25, 1.15–
1.35), diabetes mellitus (hazard ratio = 1.40, 1.32–1.47),
heart failure (hazard ratio = 2.06, 1.97–2.17), and prior
stroke(hazard ratio = 1.53, 1.44–1.62).
When myocardial infarction, stroke, angina, transient
ischemic attack, and cardiovascular death are evaluated as
a cluster endpoint, 10 of the 11 risk factors were signifi-
cantly predictive (p ≤  0.0006) of future events: male gen-
der (hazard ratio = 1.29, 1.23–1.36), age over 65 years
(hazard ratio = 1.78, 1.67–1.89), atrial fibrillation (haz-
ard ratio = 1.24, 1.13–1.36), angina (hazard ratio = 1.25,
1.19–1.32), diabetes mellitus (hazard ratio = 1.35, 1.28–
1.43), heart failure (hazard ratio = 1.59, 1.51–1.68),
hypertension (hazard ratio = 1.11, 1.06–1.17), prior myo-
cardial infarction (hazard ratio = 1.27, 1.19–1.35), prior
stroke (hazardratio = 1.51, 1.42–1.62), and prior tran-
sient ischemic attack (hazard ratio = 1.12, 1.05–1.20).
The extent to which the risk increases depends on the
number of risk factors present at diagnosis of peripheral
arterial disease (Figure 2). Compared to patients with no
risk factors at diagnosis (n = 516), presence of one or more
risk factors increases the risk of myocardial infarction by
4.08%, of stroke by 5.04% and of death by 5.82%.
To further examine the impact of a prior diagnosis of
myocardial infarction or stroke, the 27.7% of patients
with at least one of these conditions were evaluated sepa-
rately. Even in this group, occurrence of a subsequent
myocardial infarction was significantly increased with
male gender (hazard ratio = 1.57, 1.30–1.90), age over 65
years (hazard ratio = 1.20, 1.00–1.44), angina (hazard
ratio = 1.44, 1.21–1.72), diabetes mellitus (hazard ratio =
1.28, 1.06–1.54), and hypertension (hazard ratio = 1.30,
1.09–1.55).BMC Cardiovascular Disorders 2005, 5:14 http://www.biomedcentral.com/1471-2261/5/14
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As the study spans more than a decade, the effect of calen-
dar time was examined. Patients diagnosed after January
1, 1990 had an 11.1 % lower risk of subsequent myocar-
dial infarction but there was no effect on stroke or death.
Amongst patients with a history of myocardial infarction
or stroke, the risk of myocardial infarction was reduced
(by 22.3%) for patients with their peripheral arterial dis-
ease diagnosed in the 1990s.
Discussion
Although awareness of peripheral arterial disease and the
factors associated with its onset has improved in recent
years, to our knowledge, this study provides the first large-
scale, long-term comprehensive analyses of the prognosis
of patients diagnosed with peripheral arterial diseaseto-
gether with a comparison to those diagnosed first with
myocardial infarction or stroke [3-11,14-18]. These anal-
yses expand on current knowledge by providing quantita-
tive estimates of the risks faced by patients diagnosed with
peripheral arterial disease and the impact of
comorbidities.
A diagnosis of peripheral arterial disease emerged from
our analyses as critical evidence of more widespread
atherothrombotic disease. The risk of subsequent cardio-
vascular events is substantial among patients diagnosed
with peripheral arterial disease even when prior athero-
thrombotic disease (myocardial infarction and prior
ischemic stroke) is considered. The majority of these
patients have additional cardiovascular risk factors at the
time of diagnosis, thus contributing to these increased
risks.
Relative event risk Figure 2
Relative event risk. Risk increase in events for various levels of risk factors, compared to no risk factor.
Hazard Ratio
7+ RF
6R F
5R F
4R F
3R F
2R F
1R F
0 5 10 15 20 25
Death
Stroke
MIBMC Cardiovascular Disorders 2005, 5:14 http://www.biomedcentral.com/1471-2261/5/14
Page 7 of 8
(page number not for citation purposes)
In comparisons with patients suffering an acute stroke or
myocardial infarction, comparable proportions of
patients with peripheral arterial disease suffered subse-
quent events and death. Generally, risks among patients
with peripheral arterial disease were observed to be lower
than those suffering a stroke and higher than those
experiencing a myocardial infarction. Exceptions included
higher rates of subsequent myocardial infarction and
angina among patients in the myocardial infarction group
and lower rates of myocardial infarction and transient
ischemic attack among patients in the stroke group. These
results suggest that patients diagnosed with peripheral
arterial disease are at comparable risks for experiencing
subsequent events.
These findings are consistent with those of patients in a
six-year follow-up study who were identified as having
disease on non-invasive screening measurement of the
ankle-brachial index. Approximately half suffered a major
acute event (stroke or myocardial infarction) or under-
went major surgery (amputation or vascular surgery)
within six years of referral to a specialty clinic [17].
Another one quarter of patients died during this period.
Over ten years, this estimate is notably higher with 62% of
men and 33% of women expiring within this time-more
than two times the rate observed in men without a diag-
nosis of peripheral arterial disease and approximately
twice the rate among women [18]. Concomitant diag-
noses, such as diabetes mellitus and hypertension were
associated with significant risk of morbidity and mortal-
ity. As well, atrial fibrillation was linked to an increase in
acute emergency admissions and in-hospital mortality in
a recent study of patients with symptomatic peripheral
arterial disease [19]. Evaluation of the medical treatment
received by patients in this cohort was beyond the scope
of this study and was not considered in our analyses.
Analyses conducted using administrative data such as
those we used from Saskatchewan Health have some
limitations. Definition of the populations and identifica-
tion of events is dependent on accuracy of the ICD-9
codes submitted to Saskatchewan Health. Validation
work has indicated, however, a low error rate for cardio-
vascular diagnoses [12]. Another problem with adminis-
trative data is that they do not contain clinical
information such as results of laboratory tests, smoking,
family history, blood pressure, and so on. Thus, these
potentially relevant factors could not be incorporated in
the analyses.
Conclusion
Despite prior data in favor of treating peripheral arterial
disease as evidence of disseminated atherothrombosis,
the management of patients with this diagnosis remains
less aggressive than for patients suffering cardiovascular
events [3,20]. The results of this study reinforce the call for
attention to peripheral arterial disease as a serious diagno-
sis with important implications for patient management.
In particular, identification of other risk factors and risk
reduction through pharmacologic or other management
strategies ought to be aggressively pursued in this popula-
tion, as is already common practice among patients who
suffer a myocardial infarction or stroke.
Abbreviations
CI: Confidence Interval
ICD-9: International Classification of Diseases, version 9
MI: Myocardial Infarction
PAD: Peripheral Arterial Disease
PY: Person-Years
RF: Risk Factors
TIA: Transient Ischemic Attack
Competing interests
This research was supported in part by an unrestricted
grant from Sanofi-Aventis & Bristol-Myers Squibb. Nei-
ther funding agency had any role in the design, execution
of the analyses, their interpretation, or the writing of the
paper. The authors had sole responsibility for all method-
ological decisions.
Authors' contributions
JC designed the study, participated in the data analyses
and writing of the paper. KMW participated in the study
design, data analyses and in writing the paper. KJI. led the
analyses and participated in writing the paper. IP con-
ducted the analyses and helped write the paper.
Acknowledgements
This study is based in part on de-identified data provided by the Saskatch-
ewan Department of Health. The interpretation and conclusions contained 
herein do not necessarily represent those of the Government of Saskatch-
ewan or the Saskatchewan Department of Health.
References
1. Stoffers HE, Rinkens RP, Kester AD, Kaiser V, Knottnerus JA: The
prevalence of asymptomatic and unrecognized peripheral
arterial occlusive disease.  Int J Epidemiol 1996, 25:282-290.
2. Selvin E, Erlinger TP: Prevalence and risk factors for peripheral
arterial disease in the United States. Results from the
National Health and Nutrition Examination Survey, 1999–
2000.  Circulation 2004, 110:738-743.
3. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager
MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME,
McDermott MM, Hiatt WR: Peripheral arterial disease detec-
tion, awareness, and treatment in primary care.  JAMA 2001,
286:1317-1324.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cardiovascular Disorders 2005, 5:14 http://www.biomedcentral.com/1471-2261/5/14
Page 8 of 8
(page number not for citation purposes)
4. Criqui MH: Systematic atherosclerosis risk and the mandate
for intervention in atherosclerotic peripheral arterial
disease.  Am J Cardiol 2001, 88(suppl 2):43-47.
5. Weitz JI, Byrne J, Clagett P, Farkouh ME, Porter JM, Sackett DL,
Strandness DE, Taylor LM: Diagnosis and treatment of chronic
arterial insufficiency of the lower extremities: A critical
review.  Circulation 1996, 94:3026-3049.
6. Criqui MH: Peripheral arterial disease – epidemiological
aspects.  Vasc Med 2001:3-7.
7. Price PF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG: Rela-
tionship between smoking and cardiovascular risk factors in
the development of peripheral arterial disease and coronary
artery disease.  Eur Heart J 1999, 20:344-353.
8. McDermott MM, Greenland P, Liu K, Guralnik JM, Crique MH, Dolan
NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E,
Gibson D, Martin GJ: Leg symptoms in peripheral arterial dis-
ease: Associated clinical characteristics and functional
impairment.  JAMA 2001, 286:1599-1606.
9. Hooi JD, Stoffers HE, Kester AD, Rinkens PE, Kaiser V, van Ree JW,
Knottnerus JA: Risk factors and cardiovascular diseases associ-
ated with asymptomatic peripheral arterial occlusive dis-
ease. The Limburg PAOD Study. Peripheral Arterial
Occlusive Disease.  Scand J Prim Health Care 1998, 16:177-182.
10. Fowkes F, Housley E, Cawood EH, MacIntyre CC, Ruckley CV, Pres-
cott RJ: Edinburgh Artery Study: Prevalence of asymptomatic
and symptomatic peripheral arterial disease in the general
population.  Int J Epidemiol 1991, 20:384-392.
11. Newman AB: Peripheral arterial disease: Insights from popu-
lation studies of older adults.  J Am Geriatr Soc 2000,
48:1157-1162.
12. Downey W, Beck P, McNutt M, Stang MR, Osei W, Nichol J: Health
Databases in Saskatchewan.  In Pharmacoepidemiology Third edi-
tion. Edited by: Strom BL. Chichester: Wiley; 2000:325-345. 
13. Stergachis A, Sheingold S, Luce BR, Psaty BM, Revicki DA: Medical
care and cost outcomes after pentoxifylline treatment for
peripheral arterial disease.  Arch Intern Med 1992, 152:1220-1224.
14. Meijer WT, Grobbee DE, Hunink MGM, Hofman A, Hoes AW:
Determinants of peripheral arterial disease in the elderly:
The Rotterdam Study.  Arch Intern Med 2000, 160:2934-2938.
15. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Yaari S, Goldbourt U:
Intermittent claudication in 8343 men and 21-year specific
mortality follow-up.  Ann Epidemiol 1997, 7:180-187.
16. Hiatt WR: Medical treatment of peripheral arterial disease
and claudication.  N Engl J Med 2001, 344:1608-1621.
17. Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS: Rela-
tionship of severity of lower limb peripheral vascular disease
to mortality and morbidity: A six-year follow-up study.  J Vasc
Surg 1989, 9:691-697.
18. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann
TJ, Browner D: Mortality over a period of 10 years in patients
with peripheral arterial disease.  N Engl J Med 1992,
326:381-386.
19. Conway DSG, Lip GYH: Comparison of outcomes of patients
with symptomatic peripheral artery disease with and with-
out atrial fibrillation (the West Birmingham Atrial Fibrilla-
tion Project).  Am J Cardiol 2004, 93:1422-1425.
20. McDermott MM, Mehta S, Ahn H, Greenland P: Atherosclerotic
risk factors are less intensively treated in patients with
peripheral arterial disease than in patients with coronary
artery disease.  J Gen Intern Med 1997, 12:209-215.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2261/5/14/prepub